1995
DOI: 10.1016/0893-133x(94)00084-d
|View full text |Cite
|
Sign up to set email alerts
|

The Acute Effects of Reserpine and NSD-1015 on the Brain Serotonin Synthesis Rate Measured by an Autoradiographic Method

Abstract: The rate of serotonin (5-HT) synthesis was measured in the discrete regions of the rat brain utilizing an autoradiographic method and a[ 14 CJ methyl-L-tryptophan as a tracer after an acute treatment with reserpine (10 mg/kg IP) or NSD-1015 (m-hydroxybenzylhydrazine) (100 mg/kg IPIn the 1970s and the 1980s abundant investigations of the central serotoninergic system has led to the conclusion that serotonin (5-HT) plays a role in the regulation 1993 (abstract No. 126.18).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
13
0

Year Published

1995
1995
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(15 citation statements)
references
References 31 publications
2
13
0
Order By: Relevance
“…Blockade of terminal 5-HT 1B autoreceptors with GR 127935 increased 5-HIAA concentrations and the 5-HIAA/5-HT ratio considerably more than 5-HTP accumulation in non-pretreated animals (Stenfors et al 1999, the present study). However, it is also possible that the difference is due to an effect introduced by NSD 1015, since this compound may itself increase 5-HT synthesis (Mück-Šeler and Diksic 1995). If so, NSD 1015 is not the optimal decarboxylase inhibitor for studies of the 5-HTP accumulation in vivo.…”
Section: Discussionmentioning
confidence: 97%
“…Blockade of terminal 5-HT 1B autoreceptors with GR 127935 increased 5-HIAA concentrations and the 5-HIAA/5-HT ratio considerably more than 5-HTP accumulation in non-pretreated animals (Stenfors et al 1999, the present study). However, it is also possible that the difference is due to an effect introduced by NSD 1015, since this compound may itself increase 5-HT synthesis (Mück-Šeler and Diksic 1995). If so, NSD 1015 is not the optimal decarboxylase inhibitor for studies of the 5-HTP accumulation in vivo.…”
Section: Discussionmentioning
confidence: 97%
“…The hypothesis related to a need to replenish the neuronal releasable pool is also supported by a reported increase in the extracellular fluorescence and without a change in the intracellular fluorescence for 5-HT after fluoxetine treatment [9], the results of which can be observed only if 5-HT synthesis has been increased to replenish the depleted extracellular pool. Similarly, other drugs that release and/or reduce intracellular 5-HT stores such as reserpine, 3,4-methylenedioxymethamphetamine and fenfluramine, produce increases in 5-HT synthesis at the terminal areas [16,24,29,56]. Further, fluoxetine increased 5-HT synthesis at several brain areas in conscious rats [25,48].…”
Section: Discussionmentioning
confidence: 99%
“…Then 100 μL of the incubation cocktail was added and the mixture was incubated at 30°C for an additional 10min to initiate the reaction. The incubation mixture was prepared by adding 0.25mM L – tryptophan, 0.4 mM (6R)-l-erythro-tetrahydrobiopterin, 0.5 mM NADH (nicotinamide adenine dinucleotide, 1 mM NSD-1015 (aromatic amino acid decarboxylase inhibitor/3-Hydroxybenzylhydrazine dihydrochloride; Sigma), 4.5 μg/mL dihydropteridine reductase from sheep liver (Sigma), 2 mg/mL catalase (Sigma), and 0.1M potassium phosphate (pH 6.9) (Sigma) [47]. NSD 1015 is added to aid in the accumulation of 5-hydroxy tryptophan the direct product of TPH’s enzymatic activity.…”
Section: Methodsmentioning
confidence: 99%